Marina Shcherba, DO
Gastrointestinal Oncologist
My Role at MSKWe post reviews for MSK healthcare providers who have at least 30 patient experience surveys completed. If you do not see reviews for a provider, it may be because they do not yet have enough survey responses, or the provider may not be part of the group of healthcare providers included in the survey.
Only outpatient providers are included in the survey. Healthcare providers who only work in the hospital or in urgent care are not included in the survey. Pathologists or researchers who do not provide direct care to patients do not have reviews.
Request an Appointment
About Me
- Assistant Attending Physician
I am a board-certified internist, medical oncologist, and hematologist with a primary focus and expertise in the treatment of patients with gastrointestinal cancers. I actively collaborate with a team of surgeons, radiation oncologists, radiologists, and pathologists to provide the most comprehensive and state-of-the-art care for our patients.
I see patients at MSK Monmouth.
Read more
Shortly after completing my training, I joined Memorial Sloan Kettering Cancer Center (MSK), where I take care of patients with gastrointestinal malignancies including esophageal, gastric, liver, pancreatic, biliary, and colorectal cancers. I actively participate in biweekly meetings with my colleagues from the gastrointestinal oncology group in Manhattan and across other regional centers to deliver individualized and high-quality care. Molecular testing of tumors and appropriately directed therapies are available to our patients to ensure best outcomes. Due to my strong interest and background in both basic science and clinical research, I routinely discuss and enroll patients in available clinical trials open at MSK Monmouth. I also help guide patients towards clinical trials available only in Manhattan.
As a member of MSK’s oncology team in New Jersey, I strive to deliver comprehensive and sensible care to people from the community by adhering to the common high standards across MSK. Treating cancer is not limited to the disease itself and includes many other psychological and social aspects of care, with continuous support of patients and their families along the way. Compassion, empathy, and guidance are essential elements of my practice. My main goal is to provide modernized care by incorporating recent advances in the field, close to our patients’ homes, in a warm and supportive environment.
A gastrointestinal (GAS-troh-EN-teh-RAH-loh-jist) oncologist is a cancer doctor with special training in the gastrointestinal (GI) system. This includes anal, colorectal, esophageal, gastric (stomach), liver, and pancreatic cancers, as well as GI stromal tumors and neuroendocrine tumors.
My Specialties
- General Medical Oncology
- Gastrointestinal Malignancies
Education
- DO, Rowan University School of Osteopathic Medicine
Residencies
- Mount Sinai Beth Israel Medical Center
Fellowships
- Albert Einstein College of Medicine
- Montefiore Medical Center
Board Certifications
- Internal Medicine
- Medical Oncology
Insurance Information
Understanding your insurance options is an important part of managing your cancer care. We have relationships with many common healthcare providers and plans.
In Network Coverage Type
PPO
In Network Coverage Type
HMO, PPO
In Network Coverage Type
HMO, EPO PPO, POS
In Network Coverage Type
PPO
In Network Coverage Type
EPO
In Network Coverage Type
EPO
In Network Coverage Type
Federal Government
In Network Coverage Type
PPO, POS, EPO, HMO
In Network Coverage Type
State Government
Don't see your carrier or plan? We can help you understand your coverage.
If you don't have health insurance or are worried that your care may not be fully covered, our financial assistance programs may be able to help.
If you have questions about insurance, call us at 646-497-9176.
Make an Appointment
New Patients
Current Patients
Contact and Location
Dr. Shcherba sees patients at one location.
Looking to see a doctor at a different location? See all MSK locations.
Colleagues
Doctors at Memorial Sloan Kettering work as teams, with specialists from all different areas. This allows us to consider all your needs together, and to give you the best possible care.
Clinical Trials
- Clinical Trials Co-Investigated by Dr. Shcherba
- A Phase 1 Study of ART-123 Plus Chemotherapy to Treat Advanced Colorectal Cancer
Memorial Sloan Kettering's doctors and scientists are constantly developing new treatments for cancer. MSK is typically running hundreds of clinical trials at a given time.
You may be able to participate in a clinical trial even if you are new to MSK. Search our online directory to find trial information and see more about who can participate.
Search clinical trialsResearch and Publications
Visit PubMed for a full listing of Dr. Shcherba’s journal articles. Pubmed is an online index of research papers and other articles from the US National Library of Medicine and the National Institutes of Health.
See all on PubMedPatient Reviews
Your trust is our main concern
We strive to keep reviews trustworthy, honest and fair. Learn more about our patient experience reviews.
Disclosures
Doctors and faculty members often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to improve patient care, and to educate the health care community.
MSK requires doctors and faculty members to report (“disclose”) the relationships and financial interests they have with external entities. As a commitment to transparency with our community, we make that information available to the public.
Marina Shcherba discloses the following relationships and financial interests:
No disclosures meeting criteria for time period
If you’re a patient at MSK and would like more information about your doctor’s external relationships, please talk with your doctor.
The information published here is for a specific annual disclosure period. There may be differences between information on this and other public sites as a result of different reporting periods and/or the various ways relationships and financial interests are categorized by organizations that publish such data.
This page and data include information for a specific MSK annual disclosure period (January 1, 2022 through disclosure submission in spring 2023). This data reflects interests that may or may not still exist. This data is updated annually.
Learn more about MSK’s COI policies here. For questions regarding MSK’s COI-related policies and procedures, email MSK’s Compliance Office at [email protected].